Review: could Neurontin cause Transplant Rejection?


Summary

Transplant rejection is found among people who take Neurontin, especially for people who are female, 50-59 old , have been taking the drug for 1 - 6 months, also take medication Prednisone, and have Renal transplant . We study 55,796 people who have side effects while taking Neurontin from FDA and social media. Among them, 26 have Transplant rejection. Find out below who they are, when they have Transplant rejection and more.

You are not alone

Join a support group for people who take Neurontin and have Transplant rejection >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>

Neurontin

Neurontin has active ingredients of gabapentin. It is often used in pain. (latest outcomes from Neurontin 56,860 users)

Transplant Rejection

Transplant rejection (a transplant material is not worked) has been reported by people with multi-organ failure, anaemia, weakness, diarrhea, agranulocytosis (latest reports from 3,138 Transplant rejection patients).

On Jul, 29, 2016

55,796 people reported to have side effects when taking Neurontin.
Among them, 26 people (0.05%) have Transplant Rejection


Number of reports submitted per year:

Could Neurontin cause Transplant rejection?

Time on Neurontin when people have Transplant Rejection *:

  • < 1 month: 28.57 %
  • 1 - 6 months: 71.43 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Transplant Rejection when taking Neurontin *:

  • female: 61.54 %
  • male: 38.46 %

Age of people who have Transplant Rejection when taking Neurontin *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 4.76 %
  • 40-49: 33.33 %
  • 50-59: 33.33 %
  • 60+: 28.57 %

Top conditions involved for these people *:

  • Renal Transplant (4 people)
  • Osteoporosis (3 people)
  • Wheezing (2 people)
  • Heparin-Induced Thrombocytopenia (2 people)
  • Anxiety (2 people)

Top co-used drugs for these people *:

  • Prednisone (13 people)
  • Mycophenolate Mofetil (11 people)
  • Prograf (10 people)
  • Cellcept (9 people)
  • Pepcid (8 people)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Transplant rejection when taking Neurontin?

Browse all side effects of Neurontin

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Transplant rejection

Transplant rejection

Could your condition cause Transplant rejection

Transplant rejection

Can you answer these questions?

More questions for: Neurontin, Transplant rejection

You may be interested in these reviews

More reviews for: Neurontin, Transplant rejection


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.